Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Catalyst Pharmaceuticals (CPRX) Leases (2019 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Leases for 7 consecutive years, with $1.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Leases fell 13.23% year-over-year to $1.9 million, compared with a TTM value of $1.9 million through Dec 2025, down 13.23%, and an annual FY2025 reading of $1.9 million, down 13.23% over the prior year.
  • Leases was $1.9 million for Q4 2025 at Catalyst Pharmaceuticals, down from $2.0 million in the prior quarter.
  • Across five years, Leases topped out at $3.3 million in Q1 2021 and bottomed at $1.9 million in Q4 2025.
  • Average Leases over 5 years is $2.6 million, with a median of $2.6 million recorded in 2023.
  • The sharpest move saw Leases surged 25321.22% in 2021, then dropped 13.23% in 2025.
  • Year by year, Leases stood at $3.0 million in 2021, then decreased by 8.19% to $2.8 million in 2022, then dropped by 9.46% to $2.5 million in 2023, then dropped by 11.08% to $2.2 million in 2024, then dropped by 13.23% to $1.9 million in 2025.
  • Business Quant data shows Leases for CPRX at $1.9 million in Q4 2025, $2.0 million in Q3 2025, and $2.1 million in Q2 2025.